IL326139A - טיפול בסרטן עם מעכב cdk - Google Patents
טיפול בסרטן עם מעכב cdkInfo
- Publication number
- IL326139A IL326139A IL326139A IL32613926A IL326139A IL 326139 A IL326139 A IL 326139A IL 326139 A IL326139 A IL 326139A IL 32613926 A IL32613926 A IL 32613926A IL 326139 A IL326139 A IL 326139A
- Authority
- IL
- Israel
- Prior art keywords
- amino
- triazin
- oxan
- cancer
- pyrrolo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363515752P | 2023-07-26 | 2023-07-26 | |
| US202463554735P | 2024-02-16 | 2024-02-16 | |
| PCT/US2024/039552 WO2025024665A1 (en) | 2023-07-26 | 2024-07-25 | Treatment of cancer with a cdk inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326139A true IL326139A (he) | 2026-03-01 |
Family
ID=94375747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326139A IL326139A (he) | 2023-07-26 | 2024-07-25 | טיפול בסרטן עם מעכב cdk |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4750476A1 (he) |
| KR (1) | KR20260087576A (he) |
| AU (1) | AU2024301095A1 (he) |
| IL (1) | IL326139A (he) |
| WO (1) | WO2025024665A1 (he) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022533939A (ja) * | 2019-05-17 | 2022-07-27 | キネート バイオファーマ インク. | 線維芽細胞増殖因子受容体キナーゼの阻害剤 |
| AU2023212957A1 (en) * | 2022-01-25 | 2024-08-22 | Kinnate Biopharma Inc. | Inhibitors of cdk4/6 kinase |
-
2024
- 2024-07-25 EP EP24846500.7A patent/EP4750476A1/en active Pending
- 2024-07-25 WO PCT/US2024/039552 patent/WO2025024665A1/en not_active Ceased
- 2024-07-25 KR KR1020267005804A patent/KR20260087576A/ko active Pending
- 2024-07-25 IL IL326139A patent/IL326139A/he unknown
- 2024-07-25 AU AU2024301095A patent/AU2024301095A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025024665A1 (en) | 2025-01-30 |
| KR20260087576A (ko) | 2026-06-11 |
| AU2024301095A1 (en) | 2026-03-12 |
| EP4750476A1 (en) | 2026-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4326256A4 (en) | Treating cancer with a RAF inhibition | |
| IL315996A (he) | טיפולים בסרטן באמצעות מעכבי prmt5 בשיתוף mta | |
| IL316829A (he) | מעכבי מנין-mll לטיפול בסרטן | |
| IL321326A (he) | טיפולי סרטן באמצעות מעכבי prmt5 משתפים פעולה עם mta | |
| IL312650A (he) | מעכב cdk4 לטיפול בסרטן | |
| IL326327A (he) | טיפול בסרטן הערמונית | |
| CA3310959A1 (en) | Treatment of cancer with a parg inhibitor | |
| IL314687A (he) | טיפול בסרטן | |
| CA3289173A1 (en) | Treatment of cancer with a met kinase inhibitor | |
| GB202311976D0 (en) | Treatment of cancer | |
| GB202218181D0 (en) | Treatment of cancer | |
| GB202201803D0 (en) | Treatment of Cancer | |
| HK40072722A (en) | Combination of a btk inhibitor and an mdm2 inhibitor for cancer treatment | |
| CA3294486A1 (en) | Combination therapy with mek inhibitors for the treatment of cancer | |
| IL320448A (he) | שיטות לטיפול בסרטן באמצעות סוטורסיב | |
| HK40120366A (zh) | 癌症的治疗 | |
| AU2021903147A0 (en) | A method of treating cancer | |
| HK40079140A (en) | Combination cancer therapy using chk inhibitor | |
| HK40079139A (en) | Combination cancer therapy using chk inhibitor | |
| AU2021901530A0 (en) | Treatment of a hydro-excavated mud | |
| CA3250741A1 (en) | TREATMENT OF HEMATOLOGICAL MALIGNITIES | |
| GB202018062D0 (en) | Treatment of cancer | |
| CA3270268A1 (en) | Methods of treating cancer with sotorasib | |
| HK40093441A (en) | Use of a dhodh inhibitor compound in combination cancer therapy | |
| HK40091391A (en) | Use of a dhodh inhibitor compound in combination cancer therapy |